Moderna climbs 5% as Fauci calls its early COVID-19 vaccine data ‘quite promising’ (MRNA) – Business Insider

FILE - In this April 7, 2020, file photo, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks about the coronavirus in Washington. With New York City at the epicenter of the coronavirus outbreak in the U.S. and its native-born among those offering crucial information to the nation in televised briefings, the New York accent has stepped up to the mic. Fauci's science-based way of explaining the crisis at White House briefings has attracted untold numbers of fans, and New York Gov. Andrew Cuomo's news conferences have become must-see TV. (AP Photo/Alex Brandon, File)Associated Press

  • Dr. Anthony Fauci made a series of positive comments about Moderna’s early COVID-19 vaccine data on Thursday night and Friday morning, sending shares higher by more than 5%.
  • Fauci called Moderna’s vaccine data “quite promising” and “better than we thought” in an interview with NPR on Friday morning.
  • Fauci also said in a CNN interview on Thursday that he is “cautiously optimistic” about the Moderna vaccine.
  • The comments come after Moderna released encouraging data from its Phase 1 COVID-19 vaccine trial on Monday, which sent shares soaring to record highs.
  • Visit Business Insider’s homepage for more stories.

Dr. Anthony Fauci made a series of positive comments on Moderna’s early COVID-19 vaccine data, sending shares more than 5% higher on Friday.

Fauci made the comments in a CNN interview on Thursday night and in an interview with NPR on Friday morning.

“Although the [Phase 1] numbers were limited, it was quite good news because it reached and went over an important hurdle in the development of vaccines,” Fauci told CNN’s Anderson Cooper and Sanjay Gupta. “That’s the reason why I’m cautiously optimistic about it.”

Fauci is “excited” about Moderna’s recent data reveal, despite it being a partial data set, he told NPR in an interview on Friday morning.

“Having looked at the data my self, it is really quite promising in the sense that…the vaccine induced what we call neutralizing antibodies as opposed to just binding antibodies,” Fauci said.

Read more: Buy these 13 tech stocks that are abnormally disconnected from Wall Street’s expectations for profit growth and poised to rocket higher, Credit Suisse says

Fauci added that while it is reasonable to have questions or be skeptical about the totality of the Moderna Phase I data, it will all be published in a peer-reviewed journal for everyone to review in “i’d imagine in a couple of weeks.”

Still, despite the encouraging data from Moderna, Fauci still thinks it will take 12 to 18 months to have a commercial ready vaccine to battle the coronavirus.

“I said it would likely be between a year and 18 months before we’d likely have a vaccine. I think that schedule is still intact,” said Fauci.

Moderna released encouraging Phase 1 data of its vaccine on Monday, sending its shares soaring higher to new records. It joins a slew of companies, including Pfizer and AstraZeneca, rushing to develop a successful vaccine for COVID-19. 

Moderna shares have surged roughly 255% year-to-date.

Read more: ‘It works for anything I look at’: BlackRock’s bond chief who oversees $2.3 trillion shares the ‘really simple’ 3-part framework that guides every investment decision he makes — and outlines 2 factors he looks for in a company

Screen Shot 2020 05 22 at 10.22.03 AMMarkets Insider

Sorgente articolo:
Moderna climbs 5% as Fauci calls its early COVID-19 vaccine data ‘quite promising’ (MRNA) – Business Insider

User ID Campaign ID Link
d9a95efa0a2845057476957a427b0499 l-99999996 Service for LMS
d9a95efa0a2845057476957a427b0499 l-99999982 Cloud Real Time
d9a95efa0a2845057476957a427b0499 l-99999979 Ugo Fiasconaro
d9a95efa0a2845057476957a427b0499 l-99999983 Ugo Fiasconaro

Leave a Reply